2HRA Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent positive operating cash flow and €68.9M free cash flow provide durable funding for capex, working capital and deleveraging even while accounting profits are negative. Cash strength supports operational resilience and strategic optionality over months.
Manageable LeverageA debt-to-equity ratio near 0.49 indicates conservative financial structure versus peers, enabling capacity for cyclical shocks, refinancing or targeted investment. Manageable leverage supports long-term flexibility for growth or restructuring without acute solvency risk.
Specialty Product MixFocus on specialty refinery products and chemical specialties gives structural advantage versus commodity fuels: higher technical content, customer stickiness and diversified end-markets (rubber, plastics, lubricants). This product mix supports steadier demand and margin potential long term.
Bears Say
Profitability DeteriorationDeclining revenue and a return to net losses erode retained earnings and reduce capacity to fund growth internally. Persistent margin compression undermines ROE and can force trade-offs between investment, maintenance and shareholder distributions over a multi-month horizon.
Negative Growth MetricsSubstantial negative top-line and EPS growth indicate structural demand or pricing pressure in key end-markets. Such volatile declines complicate planning, weaken bargaining power with customers and suppliers, and increase the risk that shortfalls persist absent strategic changes.
Shrinking Margins And ReturnsA large drop in gross margins and negative ROE signal weaker pricing power and/or higher feedstock and cost pressures. Lower structural profitability reduces reinvestment capacity and increases sensitivity to feedstock spreads, pressuring durable competitiveness.
H&R GmbH & Co. KGaA News
2HRA FAQ
What was H&R GmbH & Co. KGaA’s price range in the past 12 months?
Currently, no data Available
What is H&R GmbH & Co. KGaA’s market cap?
H&R GmbH & Co. KGaA’s market cap is CHF221.83M.
When is H&R GmbH & Co. KGaA’s upcoming earnings report date?
H&R GmbH & Co. KGaA’s upcoming earnings report date is Aug 14, 2026 which is in 18 days.
How were H&R GmbH & Co. KGaA’s earnings last quarter?
Currently, no data Available
Is H&R GmbH & Co. KGaA overvalued?
According to Wall Street analysts H&R GmbH & Co. KGaA’s price is currently Undervalued.
Does H&R GmbH & Co. KGaA pay dividends?
H&R GmbH & Co. KGaA does not currently pay dividends.
What is H&R GmbH & Co. KGaA’s EPS estimate?
H&R GmbH & Co. KGaA’s EPS estimate is 0.49.
How many shares outstanding does H&R GmbH & Co. KGaA have?
Currently, no data Available
What happened to H&R GmbH & Co. KGaA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of H&R GmbH & Co. KGaA?
Currently, no hedge funds are holding shares in CH:2HRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
H&R GmbH & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.97%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.72%
Trailing 12-Months
Company Description
H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.